MESUPRON® Met Its Primary Objective Of Demonstrating Efficacy In The Proof Of Concept

		HER2 Support Group Forums > Breast Cancer Newsfeed
MESUPRON® Met Its Primary Objective Of Demonstrating Efficacy In The Proof Of Concept

06-19-2012, 01:13 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,946	MESUPRON® Met Its Primary Objective Of Demonstrating Efficacy In The Proof Of Concept WILEX AG (ISIN DE0006614720 / WL6 / Frankfurt Stock Exchange) published data last week from its Phase II trial with its oral drug candidate MESUPRON® in first line treatment of patients with HER2-receptor negative metastatic breast cancer... More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:28 PM.